Top 70 Contractors in NAICS 325411: Medicinal and Botanical Manufacturing, FY2025

Parent companies by net contract obligations Oct 1, 2024 – Sep 30, 2025 Code page on GovTribe

The top 10 won 100% of FY2025 NAICS 325411 contract dollars

Ranking facts

Contract obligations
$4,925,547,215 Net of deobligations, by contracts coded NAICS 325411
Contractors
73 Parent companies with an obligation
Largest contractor
Cencora, Inc. $4.87 billion, 98.8% of obligations
Data as of

Contract actions from FPDS (SAM.gov). How the rankings work · Download all 70 rows as CSV

Full ranking

Rank Contractor Net obligations Share Trend
1
Cencora, Inc. Through Amerisourcebergen Drug Corp
$4,869,922,126
Rank history: #2 in FY2021, #2 in FY2022, #2 in FY2023 and #1 in FY2024; unchanged since FY2024.
2
Emergent Biosolutions Inc. Through Emergent Biodefense Operations Lansing LLC
$20,802,000
Rank history: #6 in FY2021, not on the FY2022–FY2023 lists and #4 in FY2024; up 2 since FY2024.
3 $15,081,353
Rank history: #3 in FY2021, #3 in FY2022, #4 in FY2023 and #3 in FY2024; unchanged since FY2024.
4 $5,272,104
Rank history: #5 in FY2021, #6 in FY2022, #6 in FY2023 and #5 in FY2024; up 1 since FY2024.
5 $2,451,903
Rank history: #8 in FY2021, #10 in FY2022, #9 in FY2023 and #9 in FY2024; up 4 since FY2024.
6 $1,686,407
Rank history: not on the FY2021–FY2023 lists and #20 in FY2024; up 14 since FY2024.
7 $1,437,085
Rank history: #7 in FY2021, #8 in FY2022, #8 in FY2023 and #8 in FY2024; up 1 since FY2024.
8 $1,307,247
Rank history: #19 in FY2021, #24 in FY2022, #24 in FY2023 and #22 in FY2024; up 14 since FY2024.
9
Meridian Medical Technologies LLC
$992,655
Rank history: not on the FY2021–FY2023 lists and #7 in FY2024; down 2 since FY2024.
10 $967,595
Rank history: #18 in FY2021, not on the FY2022–FY2023 lists and #13 in FY2024; up 3 since FY2024.
11 $836,241
Rank history: #17 in FY2021, #23 in FY2022, #13 in FY2023 and #18 in FY2024; up 7 since FY2024.
12 $566,816
Rank history: not on the FY2021–FY2023 lists and #45 in FY2024; up 33 since FY2024.
13 $519,855
Rank history: #11 in FY2021, #16 in FY2022, #12 in FY2023 and #11 in FY2024; down 2 since FY2024.
14 $515,978
Rank history: not on the FY2021–FY2023 lists and #16 in FY2024; up 2 since FY2024.
15 $493,210
Rank history: #29 in FY2021, #26 in FY2022, #20 in FY2023 and #21 in FY2024; up 6 since FY2024.
16 $471,897
Rank history: #10 in FY2021, #7 in FY2022, not on the FY2023 list and #6 in FY2024; down 10 since FY2024.
17 $418,068
Rank history: #36 in FY2021, #27 in FY2022, #31 in FY2023 and #36 in FY2024; up 19 since FY2024.
18 $381,863
Rank history: #34 in FY2021, #25 in FY2022, #15 in FY2023 and #14 in FY2024; down 4 since FY2024.
19 $315,856
Rank history: #16 in FY2021, #17 in FY2022, #11 in FY2023 and #30 in FY2024; up 11 since FY2024.
20 $300,127
Rank history: #20 in FY2021, #32 in FY2022, #19 in FY2023 and #26 in FY2024; up 6 since FY2024.
21 $243,625
Rank history: #21 in FY2021, #11 in FY2022, #17 in FY2023 and #19 in FY2024; down 2 since FY2024.
22 $235,177
Rank history: not on the FY2021–FY2023 lists and #23 in FY2024; up 1 since FY2024.
23
MR Unlimited LLC
$229,008
Rank history: not on the FY2021–FY2022 lists, #37 in FY2023 and #46 in FY2024; up 23 since FY2024.
24 $224,201
Rank history: #25 in FY2021, #30 in FY2022, #25 in FY2023 and #28 in FY2024; up 4 since FY2024.
25 $216,785
Rank history: not on the FY2021–FY2023 lists and #33 in FY2024; up 8 since FY2024.
26 $195,662
Rank history: not on the FY2021–FY2024 lists; new.
27 $173,852
Rank history: #23 in FY2021, #31 in FY2022, #27 in FY2023 and #29 in FY2024; up 2 since FY2024.
28 $136,605
Rank history: not on the FY2021–FY2022 lists, #21 in FY2023 and #15 in FY2024; down 13 since FY2024.
29
Bachem Americas Inc.
$127,699
Rank history: not on the FY2021–FY2024 lists; new.
30 $121,115
Rank history: not on the FY2021–FY2022 lists, #29 in FY2023 and #32 in FY2024; up 2 since FY2024.
31
Sagent Pharmaceuticals Inc.
$102,411
Rank history: #15 in FY2021, #19 in FY2022, #26 in FY2023 and #27 in FY2024; down 4 since FY2024.
32
UIC Parent Corporation Through Curia Global Inc.
$82,310
Rank history: not on the FY2021–FY2022 lists, #16 in FY2023 and #24 in FY2024; down 8 since FY2024.
33 $77,341
Rank history: not on the FY2021 list, #38 in FY2022, #33 in FY2023 and #37 in FY2024; up 4 since FY2024.
34
Bausch & Lomb Incorporated 2 awardees
$76,202
Rank history: #46 in FY2021, #40 in FY2022, #38 in FY2023 and #35 in FY2024; up 1 since FY2024.
35 $71,875
Rank history: not on the FY2021–FY2024 lists; new.
36
Avkare LLC
$64,220
Rank history: #47 in FY2021, #64 in FY2022, #43 in FY2023 and #39 in FY2024; up 3 since FY2024.
37 $64,023
Rank history: #70 in FY2021, #45 in FY2022, #34 in FY2023 and #38 in FY2024; up 1 since FY2024.
38 $54,838
Rank history: #49 in FY2021, not on the FY2022–FY2023 lists and #47 in FY2024; up 9 since FY2024.
39 $34,945
Rank history: #1 in FY2021, #1 in FY2022, not on the FY2023 list and #64 in FY2024; up 25 since FY2024.
40 $34,134
Rank history: #42 in FY2021, #46 in FY2022, #42 in FY2023 and #44 in FY2024; up 4 since FY2024.
41 $33,296
Rank history: not on the FY2021 list, #62 in FY2022, not on the FY2023 list and #55 in FY2024; up 14 since FY2024.
42 $28,927
Rank history: not on the FY2021 list, #39 in FY2022 and not on the FY2023–FY2024 lists; returned.
43 $21,736
Rank history: not on the FY2021–FY2023 lists and #52 in FY2024; up 9 since FY2024.
44 $20,541
Rank history: not on the FY2021–FY2024 lists; new.
45 $16,811
Rank history: not on the FY2021–FY2023 lists and #71 in FY2024; up 26 since FY2024.
46 $14,306
Rank history: not on the FY2021–FY2023 lists and #51 in FY2024; up 5 since FY2024.
47 $14,103
Rank history: not on the FY2021–FY2024 lists; new.
48 $12,850
Rank history: not on the FY2021–FY2024 lists; new.
49
Biomerieux Inc. 2 awardees, including Biofire Defense LLC
$12,296
Rank history: not on the FY2021–FY2024 lists; new.
50 $9,753
Rank history: not on the FY2021–FY2023 lists and #60 in FY2024; up 10 since FY2024.
51 $8,040
Rank history: not on the FY2021–FY2024 lists; new.
52 $7,598
Rank history: not on the FY2021–FY2024 lists; new.
53 $5,600
Rank history: not on the FY2021 list, #52 in FY2022, #47 in FY2023 and #59 in FY2024; up 6 since FY2024.
54 $5,358
Rank history: not on the FY2021–FY2024 lists; new.
55 $5,245
Rank history: #77 in FY2021, not on the FY2022–FY2023 lists and #70 in FY2024; up 15 since FY2024.
56 $4,671
Rank history: not on the FY2021–FY2023 lists and #72 in FY2024; up 16 since FY2024.
57 $2,498
Rank history: not on the FY2021–FY2024 lists; new.
58
Pacific Star Corporation
$2,495
Rank history: not on the FY2021–FY2022 lists, #66 in FY2023 and #74 in FY2024; up 16 since FY2024.
59
Valneva USA Inc.
$1,740
Rank history: not on the FY2021–FY2024 lists; new.
60 $1,712
Rank history: not on the FY2021–FY2024 lists; new.
61
Alvogen Group Inc. Through Alvogen, Inc.
$1,513
Rank history: not on the FY2021–FY2024 lists; new.
62
Sanofi Pasteur Inc. Through Sanofi Vaccines US Inc.
$1,112
Rank history: not on the FY2021–FY2023 lists and #66 in FY2024; up 4 since FY2024.
63 $920
Rank history: not on the FY2021–FY2024 lists; new.
64 $630
Rank history: #55 in FY2021, #68 in FY2022, #61 in FY2023 and not on the FY2024 list; returned.
65 $576
Rank history: not on the FY2021–FY2024 lists; new.
66 $525
Rank history: not on the FY2021–FY2024 lists; new.
67
Alexion Pharmaceuticals Inc Through Astrazeneca Pharmaceuticals LP
$500
Rank history: not on the FY2021–FY2024 lists; new.
68 $395
Rank history: not on the FY2021–FY2022 lists, #44 in FY2023 and #65 in FY2024; down 3 since FY2024.
69 $21
Rank history: not on the FY2021–FY2023 lists and #67 in FY2024; down 2 since FY2024.
70 $9
Rank history: not on the FY2021–FY2024 lists; new.
Show 45 more

70 of 73 contractors listed here. See the rest on GovTribe.

How this ranking works

  • Source: every contract action FPDS records (as published on SAM.gov) in the period, as GovTribe received it.
  • Amounts are net obligations: what was obligated, less what was deobligated. Shares are of $4.93 billion obligated before deobligations, so they never pass 100%.
  • Parent companies: each action counts under the ultimate parent its award record names, or under the awardee when it names none, so no dollar counts twice. Parents of the same name (Inc., LLC and the like aside) count as one company, since FPDS records a company's parent under more than one UEI over time. GovTribe corrects a few parents and names by hand; see the corrections.
  • Fiscal year 2025 ran Oct 1, 2024 – Sep 30, 2025. The Department of Defense reports its contract actions to FPDS about 90 days late, so a fiscal year is ranked once they're in, in February, and the list doesn't change after.
  • Rank changes compare with FY2024. "New" marks a company outside that period's top 500, and "Returned" one of those that was on an earlier fiscal year's list.
  • Rank lines show each company's rank on every fiscal year's list since FY2021, #1 at the top, on a scale that gives the top of the list more room. A dashed stretch spans years it wasn't on the list. The step from FY2024 takes the color of the rank change beside it.
  • Placeholder recipients FPDS uses when it names no company ("Miscellaneous Foreign Contractors" and the like) aren't ranked.

Quick answers

Who were the top 10 NAICS 325411 contractors in FY2025?

1. Cencora, Inc. ($4.87B), 2. Emergent Biosolutions Inc. ($20.8M), 3. DMS Pharmaceutical Group Inc. ($15.1M), 4. Cardinal Health, Inc. ($5.27M), 5. Fresenius Kabi, LLC ($2.45M), 6. Atlantic Diving Supply, Inc. ($1.69M), 7. Phoenix Textile Corporation ($1.44M), 8. Altitude Technologies Inc. ($1.31M), 9. Meridian Medical Technologies LLC ($993K), 10. Baxter Healthcare Corporation ($968K).

On GovTribe

Research every contractor on this list

  • Every contract, task order and IDV they hold
  • Their subsidiaries, teammates and competitors
  • Open opportunities they're positioned for
  • Alerts when they win new work